Veterinary Medicines

EURiCAN DAPPi - L, liofilizat și suspensie injectabilă

Authorised
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 16070, Inactivated
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain 16069, Inactivated
  • Canine adenovirus 2, strain DK13, Live
  • Canine parvovirus, strain T-86, Live
  • Canine distemper virus, strain BA5, Live
  • Canine parainfluenza virus, strain CGF 2004/75, Live
Download as PDF

Product identification

Medicine name:
EURiCAN DAPPi - L, liofilizat și suspensie injectabilă
Active substance:
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 16070, Inactivated
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain 16069, Inactivated
  • Canine adenovirus 2, strain DK13, Live
  • Canine parvovirus, strain T-86, Live
  • Canine distemper virus, strain BA5, Live
  • Canine parainfluenza virus, strain CGF 2004/75, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 16070, Inactivated
    80.00
    percentage protection
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain 16069, Inactivated
    80.00
    percentage protection
    /
    1.00
    millilitre(s)
  • Canine adenovirus 2, strain DK13, Live
    2.50
    log10 cell culture infective dose 50
    /
    1.00
    Dose
  • Canine parvovirus, strain T-86, Live
    4.90
    log10 cell culture infective dose 50
    /
    1.00
    Dose
  • Canine distemper virus, strain BA5, Live
    4.00
    log10 cell culture infective dose 50
    /
    1.00
    Dose
  • Canine parainfluenza virus, strain CGF 2004/75, Live
    4.70
    log10 cell culture infective dose 50
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AI02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 140171
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 11/01/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."